Silence Therapeutics plc (SLN) free cash flow

Free cash flow · fiscal 2025
-$62.33M

Silence Therapeutics plc (SLN) generated free cash flow of -$62.33M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$67.85M. Figures as of 18 Nov 2026, 13:09 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$62.33M
Highest on record
-$49.52Mfiscal 2023
Lowest on record
-$67.85Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Silence Therapeutics plc free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -$49.52M in fiscal 2023 and the lowest -$67.85M in fiscal 2024.

History · 4 fiscal years

Free cash flow by fiscal year

Silence Therapeutics plc free cash flow, year by year

Silence Therapeutics plc (SLN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$62.33M—
2024-$67.85M—
2023-$49.52M—
2022-$57.59M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on SLN

Silence Therapeutics plc, figure by figure

Silence Therapeutics plc (SLN) overview: price, valuation and scorecard

Silence Therapeutics plc free cash flow: questions and answers

What is Silence Therapeutics plc's free cash flow?

Silence Therapeutics plc (SLN) generated free cash flow of -$62.33M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$67.85M.

What are the highest and lowest free cash flow figures on record for Silence Therapeutics plc?

Across the 4 fiscal years on record (2022–2025), the highest was -$49.52M in fiscal 2023 and the lowest -$67.85M in fiscal 2024.

How is Silence Therapeutics plc's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Silence Therapeutics plc it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Silence Therapeutics plc (SLN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/SLN/free-cash-flow

Underlying data: Yahoo Finance.